KIMBERLY SOUTHAM-GEROW: Open Payments
NPI 1598316424 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 37 payments from 12 companies in 2025. Trend: 2023 $2,067 · 2024 $1,285 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $162 |
| Axsome Therapeutics, Inc. | 2 | $146 |
| Neurocrine BioSciences, Inc. | 5 | $133 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| Alkermes, Inc. | 4 | $100 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Corium, LLC | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Bausch Health US, LLC | 1 | $27 |
Products named: VRAYLAR, Auvelity, INGREZZA, SPRAVATO, ARISTADA, CAPLYTA, FANAPT, Azstarys.
Industry payments across VA — which companies pay providers there.
